VLDLR Protein (AA 28-797) (His tag)
-
- Antigène Voir toutes VLDLR Protéines
- VLDLR (Very Low Density Lipoprotein Receptor (VLDLR))
- Type de proteíne
- Recombinant
- Attributs du protein
- AA 28-797
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette VLDLR protéine est marqué à la His tag.
- Fonction
- Human VLDLR Protein
- Séquence
- Gly28-Ser797
- Attributs du produit
- Recombinant Human VLDLR Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Gly28-Ser797.
- Pureté
- > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
- Stérilité
- 0.22 μm filtered
- niveau d'endotoxine
- Less than 1EU per μg by the LAL method.
- Biological Activity Comment
- The affinity constant of 9.78 μM as determined in SPR assay (Biacore T200). See testing image for detail.
- Top Product
- Discover our top product VLDLR Protéine
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.
- Buffer
- Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- VLDLR (Very Low Density Lipoprotein Receptor (VLDLR))
- Autre désignation
- VLDLR (VLDLR Produits)
- Synonymes
- CARMQ1 Protein, CHRMQ1 Protein, VLDLRCH Protein, AA408956 Protein, AI451093 Protein, AW047288 Protein, vldlr Protein, very low density lipoprotein receptor Protein, very low density lipoprotein receptor S homeolog Protein, VLDLR Protein, Vldlr Protein, vldlr.S Protein
- Sujet
- VLDLR cerebellar hypoplasia (VLDLR-CH) is characterized by non-progressive congenital ataxia that is predominantly truncal and results in delayed ambulation, moderate-to-profound intellectual disability, dysarthria, strabismus, and seizures.VLDLR-CH is inherited in an autosomal recessive manner. Carrier testing for at-risk relatives, prenatal testing for a pregnancy at increased risk and preimplantation genetic testing are possible when the pathogenic variants in a family are known.
- Poids moléculaire
- 85.9 kDa. Due to glycosylation, the protein migrates to 115-125 kDa based on Tris-Bis PAGE result.
- Pathways
- Cellular Response to Molecule of Bacterial Origin
-